Meeting
2023 ASCO Genitourinary Cancers Symposium
Complimentary genomic, pathologic, and artificial intelligence analysis on low-grade noninvasive bladder cancer to predict downstream recurrence.
Authors
Kyle M. Rose
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Kyle M. Rose , Aram Vosoughi , Gustavo Borjas , Heather L Huelster , Philippe E. Spiess , Anders E. Berglund , Wade J. Sexton , Anirudh Joshi , Nagi B. Kumar , Roger Li
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 553)
DOI
10.1200/JCO.2023.41.6_suppl.553
Abstract #
553
Poster Bd #
M16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive genomic analysis of molecular residual disease based on circulating tumor DNA in patients with postoperative colorectal cancer.
First Author: Qingqi Hong
Poster
2023 ASCO Breakthrough
A novel pathological finding, "BABA", for a prognostic factor in oral tongue carcinoma.
First Author: Daisuke Baba
Poster
2022 ASCO Annual Meeting
Post-treatment detection of circulating methylated BCAT1 and IKZF1 as prognostic indicators for recurrence in patients with colorectal cancer.
First Author: Graeme P. Young
Poster
2022 ASCO Annual Meeting
The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence.
First Author: Tomoko Akaike